Cell and gene therapies – it’s an exciting area packed with potential that has everybody in the industry talking. This eBook collates a selection of recent articles from The Medicine Maker covering the cell and gene therapy space.
Stuart Curbishley from the UK’s University of Birmingham gives his view on the relationship between academia and the commercial pharma industry – and explains the role of academic CDMOs.
Carl June looks back on his distinguished career in CAR T research after receiving the Lifetime Achievement Award at Advanced Therapies Week. Could anyone have predicted the success of CAR T? June thinks not. “No one could have predicted what has happened in CAR T – for many reasons! For one thing, it actually worked a lot better in our initial trials in humans than it had worked in mice.”
Members of The Medicine Maker Power List also give their views on the biggest challenges facing the industry, including manufacturing, workforce development, and “ugly science.”
And more!
For even more great content covering Advanced Medicine, click here.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
